Dr. Andrew L. Pecora is recognized internationally as one of the world’s foremost experts in blood and marrow stem cell transplantation, cellular medicine and immunology research.
A certified hematologist and oncologist, Dr. Pecora has transformed the cancer program at Hackensack University Medical Center into one of the nation’s top cancer centers. At Hackensack Meridian Health, Pecora holds the titles of chief innovations officer and president of Physician Enterprise. Dr. Pecora founded and serves as executive chairman of COTA, a health care software analytics company focused on enabling value-based care delivery. Dr. Pecora was instrumental in the continued expansion of Regional Cancer Care Associates (RCCA), one of the largest oncology physician networks in the country. As founder of RCCA, his goal was to create world-class cancer care and access to research close to home for patients. He also co-founded PCT Caladrius, LLC: a company focused on development, manufacturing and delivery of cell-based therapies that sold to Hitachi.
Dr. Pecora is a professor of medicine and oncology at Georgetown University and the University of Medicine and Dentistry of New Jersey. He has led award-winning research funded by the National Cancer Institute and the American Hellenic Educational Progressive Association (AHEPA) Research Foundation. Dr. Pecora received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his fellowship in hematology/oncology at Memorial Sloan Kettering Cancer Center. Dr. Pecora has received numerous awards including the Dr. Sol J. Barer Award for Vision, Innovation and Leadership.
Dr. Pecora is married with three children and currently resides in New Jersey.